Ind-Swift Laboratories Ltd. (INDSWFTLAB): Ind-Swift Laboratories Share Price Hits Fresh 52-Week High

Ind-Swift Laboratories Ltd. rose 10.69% to Rs 314.9, touched a fresh 52-week high of Rs 320.25 and carried a market capitalisation of Rs 2,061.86 crore.

Ind-Swift Laboratories Share Price is in focus after the stock climbed to Rs 314.9 on 12 August 2026, up Rs 30.4 or 10.69% from the previous close of Rs 284.5, and touched a fresh 52-week high of Rs 320.25. At this level, the company’s market capitalisation stood at Rs 2,061.86 crore, placing it among the larger names within its listed Pharmaceuticals & Drugs industry set.

For investors tracking Ind-Swift Laboratories Share Price Today, the move stands out because it combines a strong single-session gain with a new one-year high early in the trading day. The stock opened at Rs 306, moved between Rs 300.45 and Rs 320.25, and recorded turnover of Rs 3.47 crore on volume of 1,10,097 shares. The supplied data confirms the price event clearly, but it does not establish a company-specific catalyst behind today’s rise.

That still makes this a relevant Stock Market Today development. A fresh 52-week high often brings a stock into screens for 52 Week High Stocks, Market Movers and Stocks in News, especially when the move is backed by meaningful intraday participation. Univest notes that the combination of a sharp day gain, a new yearly high and a Rs 2,061.86 crore Market Cap is enough to put Ind-Swift Laboratories Stock News on the radar even without a verified trigger in the supplied dataset.

For readers looking for Ind-Swift Laboratories News Today, the key questions are straightforward: what exactly happened in the session, how demanding is the current valuation, how does profitability compare with industry benchmarks, and where does the company sit versus similar listed peers. This Univest stock analysis addresses those points using only the verified figures available in the dataset.

Ind-Swift Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 314.9
Previous Close	Rs 284.5
Today's Change	+Rs 30.4 (+10.69%)
Day Open	Rs 306
Fresh 52-Week High	Rs 320.25
Day Low	Rs 300.45
Current Volume	1,10,097
Turnover	Rs 3.47 crore
Market Capitalisation	Rs 2,061.86 crore

Ind-Swift Laboratories Ltd. (INDSWFTLAB) traded at Rs 314.9. versus the previous close of Rs 284.5, a rise of 10.69%. The stock opened at Rs 306, reached Rs 320.25, touched Rs 300.45. Reported volume was 1,10,097.

Ind-Swift Laboratories Share Price Today reflects a strong upward session, with the stock opening at Rs 306, rising as high as Rs 320.25 and staying well above the previous close of Rs 284.5. The 10.69% gain and fresh 52-week high show a clear one-day breakout in price action.

The session data shows that Ind-Swift Laboratories Share Price moved sharply higher from the prior close of Rs 284.5 to trade at Rs 314.9. In absolute terms, that is a Rs 30.4 increase. The day’s range of Rs 300.45 to Rs 320.25 indicates that the stock remained elevated throughout the session rather than briefly spiking and retreating to the previous close. That pattern usually attracts attention in Share Market Today screens focused on Top Gainers Today and breakout stocks.

The fact that the current price of Rs 314.9 remained close to the day high of Rs 320.25 also matters. It suggests that much of the gain was retained after the opening move, instead of being fully sold into. Turnover of Rs 3.47 crore and traded volume of 1,10,097 shares show that the move was accompanied by measurable participation, making this more than a purely notional mark-up in the last traded price.

For traders and long-term trackers alike, Ind-Swift Laboratories Share Price Live now sits at a fresh 52-week peak, while the day high itself reset the stock’s one-year high at Rs 320.25. Because the supplied data does not include a previous 52-week high reference, the exact breakout percentage above the earlier peak cannot be stated here. Even so, the price event is clear: the stock has entered new one-year-high territory and that naturally shifts attention toward whether valuation and business-quality metrics justify the heightened focus. That is the next step in this Univest Share Price Update.

Ind-Swift Laboratories Ltd. (INDSWFTLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 2,061.86 crore
P/E Ratio	43.16x
P/B Ratio	1.65x
ROE	-0.78%
ROCE	8.31%
EPS	Rs 6.59
Book Value Per Share	Rs 171.98
Dividend Yield	0%

Ind-Swift Laboratories Ltd. was valued at a P/E ratio of 43.16x, a P/B ratio of 1.65x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 6.59, book value per share of Rs 171.98, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	43.16x
Benchmark Median P/E	18.58x
Benchmark Average P/E	60.78x
Benchmark P/E Range	0x to 3,374.81x
Company P/B Ratio	1.65x
Benchmark Median P/B	1.82x
Company ROE	-0.78%
Benchmark Median ROE	10.49%
Company ROCE	8.31%
Benchmark Median ROCE	12.97%
Company Market Capitalisation	Rs 2,061.86 crore
Benchmark Median Market Cap	Rs 145.18 crore

Ind-Swift Laboratories Ltd. (INDSWFTLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 43.16x, which is above the benchmark median of 18.58x, a difference of +132.29%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROE of -0.78%, which is below the benchmark median of 10.49%, a difference of -107.44%. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROCE of 8.31%, which is below the benchmark median of 12.97%, a difference of -35.93%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Indoco Remedies Ltd.	INDOCO	2,038.53	355.2	1.99	12.85	15.67
Venus Remedies Ltd.	VENUSREM-BE	2,031.58	18.16	3.07	9.85	7.89
Fredun Pharmaceuticals Ltd.	FREDUN	2,014.34	48.16	7.19	11.42	13.15
Sakar Healthcare Ltd.	SAKAR	2,013.17	58.79	6.34	11.88	13.16
Hester Biosciences Ltd.	HESTERBIO	2,128.33	15.51	4.64	16.17	14.12

Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 43.16x compared with the displayed peer median of 48.16x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 11.88% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 13.16%, providing a capital-efficiency comparison. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a market capitalisation of Rs 2,061.86 crore. Among the 5 peers shown, 1 have a larger market capitalisation.

Why Investors Are Watching Ind-Swift Laboratories

This stock is attracting attention because the verified data shows a strong combination of price momentum, a new one-year high and sector relevance, while the valuation and profitability readings create a more layered Fundamental Analysis debate.

• Fresh 52-week high: Ind-Swift Laboratories Share Price touched Rs 320.25 and traded at Rs 314.9, confirming a new yearly high.
• Strong day move: The stock rose Rs 30.4 or 10.69% from the previous close of Rs 284.5.
• Meaningful activity: Intraday turnover reached Rs 3.47 crore with volume of 1,10,097 shares.
• Valuation discussion: P/E at 43.16 is above the industry median of 18.58, while P/B at 1.65 is below the median of 1.82.
• Profitability contrast: ROE of -0.78% and ROCE of 8.31% are below the same-industry medians of 10.49% and 12.97%.
• Sector scale: Market capitalisation of Rs 2,061.86 crore is well above the same-industry median market cap of Rs 145.18 crore.

About Ind-Swift Laboratories

Ind-Swift Laboratories Ltd. is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the supplied dataset, that is the most direct verified description of the company’s operating space and market context. In practical terms, this places the business within the listed pharmaceutical universe that investors often compare on valuation multiples such as P/E and P/B, and on return ratios such as ROE and ROCE.

For market participants tracking Ind-Swift Laboratories NSE and Ind-Swift Laboratories BSE search interest, the company’s listed positioning matters because it is being evaluated against 135 same-industry companies and 195 companies in the broader Healthcare sector snapshot supplied here. Its market capitalisation of Rs 2,061.86 crore puts it well above the industry median company size in that benchmark set.

That context helps explain why Ind-Swift Laboratories Company News can attract attention when the stock enters a fresh 52-week high. Even without a verified event-specific catalyst in the dataset, a company of this size within Pharmaceuticals & Drugs can move quickly onto investor watchlists when price action, valuation and peer comparisons start to diverge. Univest continues to frame the name through that combined lens of Market Cap, sector placement and relative financial indicators.

Track Ind-Swift Laboratories Share Price on Univest

Use Ind-Swift Laboratories Ltd. (INDSWFTLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors who want to follow Ind-Swift Laboratories Share Price more closely can track live price moves, 52-week levels, valuation ratios and broader market context on Univest. That includes session-level Share Price Update data such as current price, previous close, day range, turnover and market capitalisation.

Univest also helps users place Ind-Swift Laboratories Share Price Today in context through peer comparison, sector benchmark analysis, profitability ratios, EPS, book value and dividend yield. For readers monitoring Ind-Swift Laboratories Stock News, this can be useful when a stock moves into a fresh one-year high and the next question shifts from price action to relative valuation and financial quality.

As today’s move shows, not every strong price event arrives with a confirmed company-specific trigger in the dataset. In such cases, a disciplined process of tracking price, sector positioning and peer metrics becomes especially important. That is where Univest adds practical structure to ongoing stock analysis without turning the discussion into a recommendation.

Frequently Asked Questions

What is the latest Ind-Swift Laboratories Share Price Today?

Ans. Ind-Swift Laboratories Share Price Today was Rs 314.9 in the supplied data. The stock was up Rs 30.4, or 10.69%, from the previous close of Rs 284.5 after touching a fresh 52-week high of Rs 320.25.

Why is Ind-Swift Laboratories Share Price rising today?

Ans. The supplied data confirms that the stock rose 10.69% and hit a fresh 52-week high, which explains why it is trending. However, the dataset does not establish any company-specific catalyst beyond the verified price and trading activity.

What was the fresh 52-week high for Ind-Swift Laboratories?

Ans. Ind-Swift Laboratories touched a fresh 52-week high of Rs 320.25 during the session. The stock opened at Rs 306, traded as low as Rs 300.45, and was quoted at Rs 314.9 in the supplied market snapshot.

How much did Ind-Swift Laboratories gain in today’s session?

Ans. The stock gained Rs 30.4 in absolute terms and rose 10.69% versus the previous close of Rs 284.5. That sharp move pushed Ind-Swift Laboratories Share Price into fresh one-year-high territory during the session.

What does today’s volume and turnover show for Ind-Swift Laboratories?

Ans. The supplied data shows traded volume of 1,10,097 shares and turnover of Rs 3.47 crore. Combined with the 10.69% price rise and new 52-week high, this indicates meaningful participation in today’s market move.

What is the market capitalisation of Ind-Swift Laboratories?

Ans. Ind-Swift Laboratories had a market capitalisation of Rs 2,061.86 crore in the supplied dataset. That is far above the same-industry median market cap of Rs 145.18 crore and also above the average of Rs 472.63 crore.

Is Ind-Swift Laboratories expensive compared with its industry?

Ans. On earnings, the company’s P/E ratio of 43.16 is above the same-industry median of 18.58 but below the average of 60.78. On book value, its P/B of 1.65 is lower than the median 1.82.

How strong are Ind-Swift Laboratories profitability metrics?

Ans. The supplied figures show ROE at -0.78% and ROCE at 8.31%. Both are below the same-industry medians of 10.49% and 12.97%, so current profitability metrics look weaker than the benchmark despite the stock’s strong price action.

What are the EPS, book value and dividend yield of Ind-Swift Laboratories?

Ans. Ind-Swift Laboratories reported EPS of 6.59, book value per share of Rs 171.98 and dividend yield of 0 in the supplied data. These figures help frame the current P/E of 43.16 and P/B of 1.65.

How does Ind-Swift Laboratories compare with peers?

Ans. Ind-Swift Laboratories has a market cap similar to Indoco Remedies, Venus Remedies, Fredun Pharmaceuticals, Sakar Healthcare and Hester Biosciences. Its P/B is lower than all five, but its ROE and ROCE trail most peers in the supplied comparison.